Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression

Aging (Albany NY). 2021 Oct 31;13(20):23871. doi: 10.18632/aging.203667. Epub 2021 Oct 31.

Pol Andrés-Benito^{1

2

3}, Raúl Domínguez⁴, Maria J Colomina⁵, Franc Llorens^{2

3}, Mònica Povedano⁴, Isidro Ferrer^{1

2

3

6

7}

¹ Department of Pathology and Experimental Therapeutics, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
² Biomedical Network Research Center on Neurodegenerative Diseases (CIBERNED), Institute Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain.
³ Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
⁴ Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
⁵ Anesthesia and Critical Care Department, Bellvitge University Hospital - University of Barcelona L'Hospitalet de Llobregat, Barcelona, Spain.
⁶ Neuropathology, Pathologic Anatomy Service, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
⁷ Institute of Neurosciences, University of Barcelona, Barcelona, Spain.

No abstract available

Keywords: correction.

Publication types